Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies

• Published in: Human cell : official journal of Human Cell Research Society 2013-06, Vol.26 (2), p.56-66
• Main Authors: Yoshida, Ayako, Okamoto, Naoki, Tozawa-Ono, Akiko, Koizumi, Hirotaka, Kiguchi, Kazushige, Ishizuka, Bunpei, Kumai, Toshio, Suzuki, Nao
• Format: Article
• Language: English
• Subjects: Biomarkers, Tumor - analysis; Biomedical and Life Sciences; Blotting, Western; Brain Neoplasms - genetics; Brain Neoplasms - secondary; Cell Biology; Chromatography, Liquid; Female; Genital Neoplasms, Female - genetics; Genital Neoplasms, Female - pathology; Gynecology; Humans; Immunohistochemistry; Life Sciences; Neoplasm Proteins - analysis; Neoplasm Proteins - genetics; Oncology; Proteomics - methods; Reproductive Medicine; Research Article; Stem Cells; Surgery; Tandem Mass Spectrometry; Transcriptome - genetics
• ISSN: 1749-0774; 0914-7470; 1749-0774
• DOI: 10.1007/s13577-012-0053-4

Brain metastases of gynecological malignancies are rare, but the incidence is increasing. Patients with brain metastases have a poor prognosis, therefore early detection and optimal management is necessary. In order to determine a new biomarker, we aimed to identify proteins that associated with brain metastases. We investigated proteins associated with brain metastases of gynecological malignancies in three patients who underwent surgical resection (stage IIb cervical cancer, stage Ib endometrial cancer, and stage IIIb ovarian cancer). Proteomic analysis was performed on formalin-fixed paraffin-embedded (FFPE) samples of the primary tumors and brain metastases, which were analyzed by liquid chromatography with tandem mass spectrometry. Thereafter, candidate proteins were identified by the Scaffold system and Mascot search program, and were analyzed using western blotting and immunohistochemistry. As a result, a total of 129 proteins were identified. In endometrial and ovarian cancers, western blotting revealed that the expression of alpha-enolase (ENO1) and triosephosphate isomerase (TPI-1) was higher and the expression of Transgelin-2 (TAGLN2) was lower in metastatic tumors than in primary tumors. On the other hand, the expression of TPI-1 and TAGLN2 was lower in metastatic tumors than in primary tumors in cervical cancer. Immunohistochemistry confirmed that ENO1 expression was elevated in the metastatic tumors compared with the primary tumors. In conclusion, the present study showed that FFPE tissue-based proteomics analysis can be powerful tool, and these findings suggested that ENO1, TPI-1, and TAGLN2 may have a role in the development and progression of brain metastasis from gynecological malignancies.